AstraZeneca (AZN)
Create an Alert
50.19
-0.79 -1.55%
NYSE
Jun 19, 8:00PM
BATS Real time
Currency in USD
AstraZeneca News
Will Amarin's Fish Oil Drug Slip Past the FDA a Second Time?
Fool Jun 19The advisory committee meeting date for the ANCHOR indication is now set.
Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo
Jun 19An FDA panel will review Vascepa on Oct. 16, and expected combo data won't matter much.
Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
Street Insider Jun 19AstraZeneca and NGM Collaborate - Analyst Blog
Zacks Jun 18AstraZeneca entered into an agreement with NGM Biopharmaceuticals, Inc. to develop candidates for type II diabetes and obesity.
Teva to Acquire MicroDose Therapeutx - Analyst Blog
Zacks Jun 18This deal is in line with Teva's strategy of strengthening its position in the respiratory therapeutic area.
Top Treatments for High Cholesterol
Fool Jun 17There's an investment opportunity, but it's going to take time to play out.
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AZN | 50.19 | -0.79 | -1.55% | 62.72B |
